The Variable Presentations and Broadening Geographic Distribution of Hepatic Fascioliasis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 6, 2012, Pages 598-602

  Rowan, Sarah E ^a   Levi, Marilyn E ^a   Youngwerth, Jean M ^b   Brauer, Brian ^b   Everson, Gregory T ^b   Johnson, Steven C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Fasciola gigantica; Fasciola hepatica; Trematode Infection; Triclabendazole

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; NITAZOXANIDE; TRICLABENDAZOLE; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; AFRICA; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EOSINOPHILIA; FASCIOLA; FASCIOLIASIS; FATIGUE; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTRANSAMINASEMIA; LEUKOCYTOSIS; LIVER HEMATOMA; MALE; SINGLE DRUG DOSE; TRAVEL; TREMATODE LIFE CYCLE STAGE; WEIGHT REDUCTION;

AFRICA; AGED; ANIMALS; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMANS; LIFE CYCLE STAGES; MALE; MIDDLE AGED; TOPOGRAPHY, MEDICAL; TRAVEL; UNITED STATES;

EID: 84861337052     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.02.013     Document Type: Article

References (24)

1. Keiser J., Utzinger J. Emerging foodborne trematodiasis. Emerging Infect Dis 2005, 11:1507-1514.
2. Marcos L.A., Terashima A., Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis, and clonorchiasis. Curr Opin Infect Dis 2008, 21:523-530.
3. Report of the WHO Informal Meeting on Use of Triclabendazole in Fascioliasis Control 2007, World Health Organization, WHO, Geneva, Switzerland.
4. Arjona R., Riancho J.A., Aguado J.M., et al. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 1995, 74:13-23.
5. Norton R.A., Monroe L. Infection by Fasciola hepatica acquired in California. Gastroenterology 1961, 41:46-48.
6. Mas-Coma S., Valero M.A., Bargues M.D. Chapter 2: Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 2009, 69:41-146.
7. Han J.K., Choi B.I., Cho J.M., et al. Radiological findings of human fascioliais. Abdom Imaging 1993, 18:261-264.
8. Gulsen M.T., Savas M.C., Koruk M., et al. Fascioliasis: a report of five cases presenting with common bile duct obstruction. Neth J Med 2006, 64:17-19.
9. Control of foodborne trematode infections: report of a WHO study group 1995, World Health Organization, World Health Organization, Geneva, Switzerland.
10. Hopkins D.R. Homing in on helminthes. Am J Trop Med Hyg 1992, 46:626-634.
11. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005, 79:207-216.
12. Hammond J.A. Infections with Fasciola spp in wildlife in Africa. Trop Anim Health Prod 1972, 4:1-13.
13. Mas-Coma M.S., Esteban J.G., Bargues M.D. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999, 77:340-346.
14. Soliman M.F. Epidemiological review of human and animal fascioliasis in Egypt. J Infect Dev Ctries 2008, 2:182-189.
15. Fanthom H.B., Braun M.G., Stephens J.W., et al. The animal parasites of man 1916, 244-245. J Bale, Sons & Danielsson Ltd, New York, Wood.
16. Hammond J.A. Human infection with the liver fluke Fasciola gigantica. Trans R Soc Trop Med Hyg 1974, 68:253-254.
17. Goldsmith J.M. Studies on intestinal helminthes in African patients at Harari Central Hospital, Rhodesia. Trans R Soc Trop Med Hyg 1968, 62:619-629.
18. Graham C.S., Brodie S.B., Weller P.F. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis 2001, 33:1-6.
19. Price T.A., Tuazon C.U., Simon G.L. Fascioliasis: case reports and review. Clin Infect Dis 1993, 17:426-430.
20. Chand M.E., Herman J.A., Partridge D.G., et al. Imported human fascioliasis, United Kingdom. Emerging Infect Dis 2009, 15:1876-1877.
21. De Kock K.N., Wolmarans C.T., Bornman M. Distribution and habitats of the snail Lymnaea truncatula, intermediate host of the liver fluke Fasciola hepatica, in South Africa. J S Afr Vet Assoc 2003, 74:117-122.
22. Hillyer G.V., Soler de Galanes M., Rodriguez-Perez J., et al. Use of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992, 46:603-609.
23. Apt W., Aguilera X., Vega F., et al. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995, 52:532-535.
24. Espinoza J.R., Maco V., Marcos L., et al. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 2007, 76:977-982.